Liu Yefang, Zeng Shaoqian, Li Yu, Zhuang Guangtong, Su Yue, Liu Xiyang, Chen Lin, Feng Quansheng
No.3 Affiliated Hospital of Chengdu University of TCM (West District), Chengdu Pidu District Hospital of TCM.
School of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu.
Medicine (Baltimore). 2020 Oct 23;99(43):e22730. doi: 10.1097/MD.0000000000022730.
Chronic obstructive pulmonary disease (COPD) is a public threat, leading to progressive physical activity and poor quality of life. Although modern medicine has excellent achievement of COPD, the recurrence rate of stable COPD and the mortality of acute exacerbation COPD remain high. As one of the external therapy of traditional Chinese medicine, acupoint application has been treated COPD in China for a long time. Nevertheless, study evaluating the effect of acupoint application for COPD could not satisfy needs for clinic.
Randomized controlled trials meeting the inclusion criteria will be collected by the 2 reviewers. We choose the following electronic databases of Web of Science, Pub Med, EMBASE, Cochrane Library, China National Knowledge Infrastructure, Wan Fang, Chinese Scientific Journals Database, and Chinese Biomedical Database as our retrieval tool. The retrieval time was from inception to March 2020. The key to evaluation criteria is total clinical efficacy rate and lung function will be measured. Secondary outcomes include assessment scales and adverse reactions. The studies extracted will be assessed. The merging analysis will be carried out by Review Manager Software.
A scientific evidence of efficacy and safety of acupoint application for COPD will be found.
The evaluation of the efficacy and safety of acupoint application for COPD will be presented.
INPLASY202090023.
慢性阻塞性肺疾病（COPD）是一种公共卫生威胁，会导致身体活动能力逐渐下降和生活质量变差。尽管现代医学在COPD治疗方面取得了卓越成就，但稳定期COPD的复发率和急性加重期COPD的死亡率仍然很高。穴位贴敷作为中医外治法之一，在中国用于治疗COPD已有很长时间。然而，评估穴位贴敷对COPD疗效的研究尚不能满足临床需求。
两名评价者将收集符合纳入标准的随机对照试验。我们选择以下电子数据库作为检索工具：Web of Science、Pub Med、EMBASE、Cochrane图书馆、中国知网、万方、维普和中国生物医学数据库。检索时间从建库至2020年3月。评价标准的关键指标是总临床有效率，并将测量肺功能。次要结局包括评估量表和不良反应。对提取的研究进行评估。采用Review Manager软件进行荟萃分析。
将找到穴位贴敷治疗COPD有效性和安全性的科学证据。
将呈现穴位贴敷治疗COPD有效性和安全性的评价结果。
INPLASY注册号：INPLASY202090023。
